The third-generation EGFR inhibitor AZD9291 overcomes primary resistance by continuously blocking ERK signaling in glioblastoma

BACKGROUND: Glioblastoma (GBM) is a fatal brain tumor, lacking effective treatment. Epidermal growth factor receptor (EGFR) is recognized as an attractive target for GBM treatment. However, GBMs have very poor responses to the first- and second-generation EGFR inhibitors. The third-generation EGFR-t...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Exp Clin Cancer Res
Главные авторы: Liu, Xuejiao, Chen, Xiangyu, Shi, Lin, Shan, Qianqian, Cao, Qiyu, Yue, Chenglong, Li, Huan, Li, Shengsheng, Wang, Jie, Gao, Shangfeng, Niu, Mingshan, Yu, Rutong
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2019
Предметы:
Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6533774/
https://ncbi.nlm.nih.gov/pubmed/31122294
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-019-1235-7
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы